1. Home
  2. BNL vs VCYT Comparison

BNL vs VCYT Comparison

Compare BNL & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadstone Net Lease Inc.

BNL

Broadstone Net Lease Inc.

HOLD

Current Price

$17.53

Market Cap

3.5B

Sector

Real Estate

ML Signal

HOLD

Logo Veracyte Inc.

VCYT

Veracyte Inc.

HOLD

Current Price

$44.65

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNL
VCYT
Founded
2007
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
2.9B
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
BNL
VCYT
Price
$17.53
$44.65
Analyst Decision
Buy
Strong Buy
Analyst Count
7
8
Target Price
$19.86
$45.38
AVG Volume (30 Days)
1.9M
978.7K
Earning Date
10-29-2025
11-04-2025
Dividend Yield
6.66%
N/A
EPS Growth
N/A
N/A
EPS
0.47
0.38
Revenue
$447,973,000.00
$495,141,000.00
Revenue This Year
$5.68
$16.02
Revenue Next Year
$7.27
$10.74
P/E Ratio
$37.15
$117.27
Revenue Growth
5.49
16.41
52 Week Low
$13.96
$22.61
52 Week High
$18.87
$50.71

Technical Indicators

Market Signals
Indicator
BNL
VCYT
Relative Strength Index (RSI) 40.34 55.12
Support Level $17.36 $45.68
Resistance Level $17.67 $48.10
Average True Range (ATR) 0.36 2.17
MACD -0.05 -0.02
Stochastic Oscillator 15.09 51.69

Price Performance

Historical Comparison
BNL
VCYT

About BNL Broadstone Net Lease Inc.

Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

Share on Social Networks: